Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1702264
PUBLISHER: IMARC | PRODUCT CODE: 1702264
Insomnia Market Size, Share, Trends and Forecast by Therapy Type, Drug Class, Distribution Channel, and Region, 2025-2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global insomnia market size was valued at USD 5.34 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.78 Billion by 2033, exhibiting a CAGR of 2.55% during 2025-2033. North America currently dominates the market, holding a significant market share of over 36.4% in 2024. Increasing prevalence due to modern lifestyles and stress, advancements in diagnostic technologies enhancing accuracy, robust research into novel therapies, rising healthcare expenditures, integration of digital health solutions, strategic industry collaborations, and growing consumer preference for non-pharmacological treatments are some of the factors bolstering the market growth. In addition to this, advanced healthcare, high sleep disorder prevalence, and adoption of innovative treatments are further increasing the insomnia market share.
Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.
Insomnia Market Trends:
The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.
Key Market Segmentation:
Breakup by Therapy Type:
- Non-Pharmacological Therapy
- Hypnotherapy
- Cognitive Behavioral Therapy
- Medical Devices
- Others
- Pharmacological Therapy
- Prescription Sleep Aids
- Over-The-Counter Sleep Aids
Breakup by Drug Class:
- Antidepressants
- Melatonin Antagonist
- Benzodiazepines
- Nonbenzodiazepines
- Orexin Antagonist
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.
Key Questions Answered in This Report
- 1.How big is the insomnia market?
- 2.What is the future outlook of insomnia market?
- 3.What are the key factors driving the insomnia market?
- 4.Which region accounts for the largest insomnia market share?
- 5.Which are the leading companies in the global insomnia market?
Product Code: SR112025A6148
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Insomnia Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Therapy Type
- 6.1 Non-Pharmacological Therapy
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Hypnotherapy
- 6.1.2.2 Cognitive Behavioral Therapy
- 6.1.2.3 Medical Devices
- 6.1.2.4 Others
- 6.1.3 Market Forecast
- 6.2 Pharmacological Therapy
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Prescription Sleep Aids
- 6.2.2.2 Over-The-Counter Sleep Aids
- 6.2.3 Market Forecast
7 Market Breakup by Drug Class
- 7.1 Antidepressants
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Melatonin Antagonist
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Benzodiazepines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Nonbenzodiazepines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Orexin Antagonist
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Drug Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Online Pharmacies
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Astellas Pharma Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Aurobindo Pharma Limited
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Biocodex
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Eisai Co. Ltd.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Mallinckrodt Pharmaceuticals
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Merck & Co. Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Neurim Pharmaceuticals Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Pfizer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sanofi S.A.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Takeda Pharmaceutical Company Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Vanda Pharmaceuticals Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.1 Astellas Pharma Inc.
Product Code: SR112025A6148
List of Figures
- Figure 1: Global: Insomnia Market: Major Drivers and Challenges
- Figure 2: Global: Insomnia Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2024
- Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2024
- Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2024
- Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: North America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: United States: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Canada: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: China: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: China: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Japan: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: India: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: India: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: South Korea: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Australia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Indonesia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Europe: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Germany: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: France: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: France: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Italy: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Spain: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Russia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Latin America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Brazil: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Mexico: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2024
- Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Global: Insomnia Industry: SWOT Analysis
- Figure 82: Global: Insomnia Industry: Value Chain Analysis
- Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Insomnia Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
- Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
- Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Insomnia Market: Competitive Structure
- Table 7: Global: Insomnia Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.